Breaking News Instant updates and real-time market news.
| 2019-11-04 16:09:13 CTIC CTI BioPharma  
| CTI BioPharma reports Q3 EPS (17c), consensus (23c)Reports Q3 revenue $2.29M. Reports Q3 operating loss $9.7M. The company commented, "We advanced our pacritinib development program in the third quarter, and recently took an important step forward for the company by initiating and enrolling the first patient in the PACIFICA trial, our pivotal Phase 3 trial of pacritinib in myelofibrosis patients with severe thrombocytopenia. An estimated one-third of patients with myelofibrosis are severely thrombocytopenic - a population with limited therapeutic options and poor survival, thereby making this disease setting a very important area of unmet medical need. In the near-term, we look forward to presenting results from the PAC203 Phase 2 trial at a scientific conference before the end of the year." | |
|---|---|---|
| ||
TODAY'S FREE FLY STORIES
| XLU Utilities SPDR
|
| |
|---|---|---|
| XLP Consumer Staples Sector SPDR
|
| |
| COO Cooper Companies
|
| |
| XLV Health Care Select Sector SPDR
|
| |
| IWM iShares Trust Russell 2000 Index Fund
|
|
| HDS HD Supply
|
| |
|---|---|---|
| DIA Diamonds Fund ETF
|
| |
| SPY SPDR S&P 500 ETF Trust
|
| |
| CNQ Canadian Natural
|
| |
| XLF Financial Select Sector
|
|
| SMH Market Vectors Semiconductor
|
| |
|---|---|---|
| QQQ Invesco QQQ Trust
|
| |
| $COMP Nasdaq Composite
|
| |
| LITE Lumentum
AT&T
|
| |
| NDX Nasdaq 100 Index
|
|
| PMBC Pacific Mercantile Bancorp
|
| |
|---|---|---|
| QCOM Qualcomm
Apple
|
| |
| DARE Dare Bioscience
|
| |
| ||
|
| ITRM Iterum Therapeutics
|
| |
|---|---|---|
| YEXT Yext
|
| |
| KLR Kaleyra
|
| |
| WINT Windtree Therapeutics
|
| |
| CSTM Constellium
|
|